Trump administration backs Bayer as Roundup fight moves toward Supreme Court
Werte in diesem Artikel
The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman Countdown" and said the government’s support could make the difference in the case. "This is a really important topic for farmers, for American consumers, and, frankly, for food security in America," Anderson said Wednesday during an exclusive interview with Liz Claman. Bayer, which acquired Roundup through its 2018 purchase of Monsanto, faces tens of thousands of lawsuits from people who say the weedkiller caused their cancer. U.S. and international health agencies disagree on that claim. BAYER ORDERED TO PAY $2.1B IN LATEST ROUNDUP WEEDKILLER LOSSThe International Agency for Research on Cancer has said glyphosate, the chemical in Roundup, is "probably carcinogenic to humans." The U.S. Environmental Protection Agency has found that the chemical is "not likely to be carcinogenic to humans" when used as directed.Bayer has already paid billions to resolve Roundup claims, and it has thousands more still pending. The company argues that because the EPA decides what goes on a pesticide label, individual states cannot require different warnings. SAN FRANCISCO SUES 10 MAJOR FOOD MANUFACTURERS OVER ULTRA-PROCESSED FOODSBayer argues it can’t be sued for leaving off a cancer warning the federal government never required, and the Trump administration agrees."Glyphosate has been tested and found safe by every major food regulator, safety regulator in the world," said Anderson, who claimed it's not a political issue."If you have hundreds of scientists paid for by taxpayer dollars who determine a product is safe, that has to count for something," he said.Earlier this month, Solicitor General D. John Sauer of the Trump administration asked the U.S. Supreme Court to take up the case. Sauer agreed that federal pesticide law should override state-level failure-to-warn lawsuits, a move that could limit, or even shut down, thousands of claims seeking compensation in court.COSTCO FILES FEDERAL LAWSUIT CHALLENGING TRUMP'S EMERGENCY TARIFF ORDERS ON IMPORTED GOODSBayer said the Solicitor General’s support is a vital part of getting the Supreme Court to consider the case."The support of the U.S. Government is an important step and good news for U.S. farmers, who need regulatory clarity," wrote Anderson in a statement. GET FOX BUSINESS ON THE GO BY CLICKING HERE"The stakes could not be higher as the misapplication of federal law jeopardizes the availability of innovative tools for farmers and investments in the broader U.S. economy," he added.The Trump administration’s support sent Bayer stock sharply higher, pushing its shares to their highest in years, according to Reuters.Weiter zum vollständigen Artikel bei FOX Business
Ausgewählte Hebelprodukte auf Bayer
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Bayer
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: FOX Business
Nachrichten zu Bayer
Analysen zu Bayer
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.12.2025 | Bayer Equal Weight | Barclays Capital | |
| 02.12.2025 | Bayer Kaufen | DZ BANK | |
| 02.12.2025 | Bayer Buy | Merrill Lynch & Co., Inc. | |
| 02.12.2025 | Bayer Neutral | JP Morgan Chase & Co. | |
| 02.12.2025 | Bayer Hold | Jefferies & Company Inc. |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.12.2025 | Bayer Kaufen | DZ BANK | |
| 02.12.2025 | Bayer Buy | Merrill Lynch & Co., Inc. | |
| 02.12.2025 | Bayer Buy | Goldman Sachs Group Inc. | |
| 27.11.2025 | Bayer Buy | Goldman Sachs Group Inc. | |
| 25.11.2025 | Bayer Kaufen | DZ BANK |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.12.2025 | Bayer Equal Weight | Barclays Capital | |
| 02.12.2025 | Bayer Neutral | JP Morgan Chase & Co. | |
| 02.12.2025 | Bayer Hold | Jefferies & Company Inc. | |
| 02.12.2025 | Bayer Neutral | UBS AG | |
| 25.11.2025 | Bayer Neutral | UBS AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.10.2019 | Bayer Verkaufen | Independent Research GmbH | |
| 21.08.2019 | Bayer Verkaufen | Independent Research GmbH | |
| 01.08.2019 | Bayer Verkaufen | Independent Research GmbH | |
| 28.06.2019 | Bayer Verkaufen | Independent Research GmbH | |
| 25.04.2019 | Bayer Verkaufen | Independent Research GmbH |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Bayer nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
